Tandem Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,246
Closed -$3.16M 83
2023
Q2
$3.16M Sell
15,246
-605
-4% -$117K 0.14% 46
2023
Q1
$3.12M Buy
15,851
+404
+3% +$83.1K 0.15% 47
2022
Q4
$3.13M Sell
15,447
-599
-4% -$117K 0.16% 46
2022
Q3
$2.82M Buy
16,046
+3,256
+25% +$667K 0.16% 45
2022
Q2
$2.58M Buy
12,790
+598
+5% +$127K 0.15% 43
2022
Q1
$2.76M Buy
12,192
+1,601
+15% +$377K 0.17% 39
2021
Q4
$2.86M Buy
10,591
+554
+6% +$137K 0.19% 37
2021
Q3
$2.43M Sell
10,037
-2,483
-20% -$626K 0.2% 36
2021
Q2
$2.97M Sell
12,520
-2,841
-18% -$647K 0.25% 36
2021
Q1
$3.37M Sell
15,361
-4,869
-24% -$977K 0.32% 32
2020
Q4
$3.54M Sell
20,230
-139
-0.7% -$24K 0.38% 32
2020
Q3
$3.29M Buy
20,369
+2,362
+13% +$374K 0.4% 33
2020
Q2
$2.57M Buy
18,007
+400
+2% +$55.3K 0.35% 38
2020
Q1
$1.91M Buy
17,607
+1,602
+10% +$231K 0.28% 42
2019
Q4
$2.33M Buy
16,005
+1,935
+14% +$279K 0.39% 35
2019
Q3
$2.03M Buy
14,070
+53
+0.4% +$7.73K 0.37% 35
2019
Q2
$2.08M Buy
+14,017
New +$1.96M 0.39% 32

Other funds holding LH

Tandem Investment Advisors's LH Position: Q3 2023 in Review

Tandem Investment Advisors sold out of Labcorp (LH) in Q3 2023, closing a stake of 15,246 shares — an estimated $3.16M sold.

Tandem Investment Advisors first reported a position in LH in Q2 2019 and held it in 17 quarters. The position peaked at $3.54M in Q4 2020. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

  • Tandem Investment Advisors reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
  • Tandem Investment Advisors sold 15,246 Labcorp shares in Q3 2023, an estimated $3.16M.
  • Tandem Investment Advisors first reported a position in Labcorp in Q2 2019 and held it in 17 quarters.
  • Tandem Investment Advisors's Labcorp position peaked at $3.54M in Q4 2020.
  • 881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Tandem Investment Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.